Rapid modulation of spine morphology by the 5-HT 2A serotonin receptor through kalirin-7 signaling
Open accessAbstract
The 5-HT 2A serotonin receptor is the most abundant serotonin receptor subtype in the cortex and is predominantly expressed in pyramidal neurons. The 5-HT 2A receptor is a target of several hallucinogens, antipsychotics, anxiolytics, and antidepressants, and it has been associated with several psychiatric disorders, conditions that are also associated with aberrations in dendritic spine morphogenesis. However, the role of 5-HT 2A receptors in regulating dendritic spine morphogenesis in cortical neurons is unknown. Here we show that the 5-HT 2A receptor is present in a subset of spines, in addition to dendritic shafts. It colocalizes with PSD-95 and with multiple PDZ protein-1 (MUPP1) in a subset of dendritic spines of rat cortical pyramidal neurons. MUPP1 is enriched in postsynaptic density (PSD) fractions, is targeted to spines in pyramidal neurons, and enhances the localization of 5-HT 2A receptors to the cell periphery. 5-HT 2A receptor activation by the 5-HT 2 receptor agonist DOI induced a transient increase in dendritic spine size, as well as phosphorylation of p21-activated kinase (PAK) in cultured cortical neurons. PAK is a downstream target of the neuronal Rac guanine nucleotide exchange factor (RacGEF) kalirin-7 that is important for spine remodeling. Kalirin-7 regulates dendritic spine morphogenesis in neurons but its role in neuromodulator signaling has not been investigated. We show that peptide interference that prevents the localization of kalirin-7 to the postsynaptic density disrupts DOI-induced PAK phosphorylation and spine morphogenesis. These results suggest a potential role for serotonin signaling in modulating spine morphology and kalirin-7's function at cortical synapses.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The 5-HT2A receptor is expressed on dendritic shafts and dendritic spines of cortical neurons in both rodents and primates.
“The 5-HT 2A R, a common target of psychedelics, is expressed on dendritic shafts and dendritic spines of cortical neurons in both rodents and primates (Jakab and Goldman-Rakic, 1998;Miner et al., 2003;Jones et al., 2009;Weber and Andrade, 2010;Yoshida et al., 2011).”
From Psychedelics and Neural Plasticity: Therapeutic Implications (2022) · cites this paper as Jones et al., 2009
DOI increases spine size in cultured cortical neurons.
“DOI, one of the more readily accessible psychedelics to researchers, has been shown to increase dendritic growth (Persico et al., 2006;Ohtani et al., 2014;Ly, Greb et al., 2018;Ly et al., 2021), synaptic puncta, spine density (Yoshida et al., 2011;Ly et al., 2018), and spine size (Jones et al., 2009) in cultured cortical neurons.”
From Psychedelics and Neural Plasticity: Therapeutic Implications (2022) · cites this paper as Jones et al., 2009
Neurotransmitters including norepinephrine, serotonin and glutamate, as well as stress-induced release of neuropeptides and steroids, can influence synapse number and function.
“Neurotransmitters, including norepinephrine,76, 77, 78 serotonin79, 80, 81 and glutamate,82,83 as well as stress-induced release of neuropeptides26,34,84,85 and steroids,86, 87, 88 can influence synapse number and function.”
From Preferential loss of dorsal-hippocampus synapses underlies memory impairments provoked by short, multimodal stress (2014) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925 · see citing works
Balancing Structure and Function at Hippocampal Dendritic Spines
Bourne, J. N., & Harris, K. M. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125646 · Cited by 916 · see citing works
Pompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 870 · see citing works
Anatomical and Physiological Plasticity of Dendritic Spines
Alvarez, V. A., & Sabatini, B. L. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094222 · Cited by 629 · see citing works
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536 · see citing works
Penzes, P., Beeser, A., Chernoff, J., Schiller, M. R., Eipper, B. A., Mains, R. E., & Huganir, R. L. (2003) · Neuron · doi:10.1016/s0896-6273(02)01168-6 · Cited by 466 · see citing works
Self-citationCortical 5-HT 2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice
Weisstaub, N., Zhou, M., Lira, A., Lambe, E. K., González‐Maeso, J., Hornung, J., Sibille, E. L., Underwood, M. D., Itohara, S., Dauer, W. T., et al. (2006) · Science · doi:10.1126/science.1123432 · Cited by 425 · see citing works
Penzes, P., Johnson, R. C., Sattler, R., Zhang, X., Huganir, R. L., Kambampati, V., Mains, R. E., & Eipper, B. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00193-3 · Cited by 378 · see citing works
Self-citationKalirin-7 Controls Activity-Dependent Structural and Functional Plasticity of Dendritic Spines
Xie, Z., Srivastava, D. P., Photowala, H., Kai, L., Cahill, M. E., Woolfrey, K. M., Shum, C. Y., Surmeier, D. J., & Penzes, P. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.005 · Cited by 373 · see citing works
Self-citationParadoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists
Gray, J. A. B., & Roth, B. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00623-2 · Cited by 296 · see citing works
Self-citationKrapivinsky, G., Medina, I., Krapivinsky, L., Gapon, S., & Clapham, D. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.003 · Cited by 287 · see citing works
Hajszán, T., MacLusky, N. J., & Leranth, C. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03968.x · Cited by 239 · see citing works
Activation of Serotonin Receptors Modulates Synaptic Transmission in Rat Cerebral Cortex
Zhou, F.-M., & Hablitz, J. J. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.6.2989 · Cited by 238 · see citing works
Hill, J. J., Hashimoto, T., & Lewis, D. A. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001792 · Cited by 228 · see citing works
Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Gray, J. A., & Roth, B. L. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm074 · Cited by 225 · see citing works
Self-citationMarek, G. J., & Aghajanian, G. K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00945-5 · Cited by 221 · see citing works
Miner, L. A. H., Backstrom, J. R., Sanders-Bush, E., & Sesack, S. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00580-8 · Cited by 216 · see citing works
霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位
Jakab, R. L., & Goldman‐Rakic, P. S. (1998) · Cited by 182 · see citing works
Blanpied, T. A., & Ehlers, M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.006 · Cited by 179 · see citing works
Xia, Z., Gray, J. A., Compton-Toth, B. A., & Roth, B. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301905200 · Cited by 178 · see citing works
Self-citationThe Serotonin 5-HT2A and 5-HT2C Receptors Interact with Specific Sets of PDZ Proteins
Bécamel, C., Gavarini, S., Chanrion, B., Alonso, G., Galéotti, N., Dumuis, A., Bockaert, J., & Marin, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312106200 · Cited by 170 · see citing works
Bécamel, C., Figge, A., Poliak, S., Dumuis, A., Peles, E., Bockaert, J., Lübbert, H., & Ullmer, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008089200 · Cited by 169 · see citing works
Temporal and Spatial Distribution of Activated Pak1 in Fibroblasts
Sells, M. A., Pfaff, A., & Chernoff, J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.7.1449 · Cited by 160 · see citing works
Dendritic spine dynamics--a key role for kalirin-7
Penzes, P., & Jones, K. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.001 · Cited by 157 · see citing works
Self-citationRapid enhancement of two-step wiring plasticity by estrogen and NMDA receptor activity
Srivastava, D. P., Woolfrey, K. M., Jones, K. A., Shum, C. Y., Lash, L. L., Swanson, G. T., & Penzes, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801581105 · Cited by 155 · see citing works
Self-citationMarta Ribasés, A., Ramos‐Quiroga, J. A., Amaia Hervas, G., Bosch, R., Bielsa, A., Gastaminza, X., Artigas-Pallarés, J., Rodriguez-Ben, S., Estivill, X., Casas, M., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002100 · Cited by 154 · see citing works
PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors
Abbas, A. I., Yadav, P. N., Yao, W.-D., Arbuckle, M. I., Grant, S. G. N., Caron, M. G., & Roth, B. L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1090-09.2009 · Cited by 137 · see citing works
Self-citationDevelopmental regulation of 5-HT2 and 5-HT1C mRNA and receptor levels
Roth, B. L., Hamblin, M. W., & Ciaranello, R. D. (1991) · Developmental Brain Research · doi:10.1016/0165-3806(91)90236-c · Cited by 123 · see citing works
Self-citationMpdz is a quantitative trait gene for drug withdrawal seizures
Shirley, R. L., Walter, N. A. R., Reilly, M. T., Fehr, C., & Buck, K. J. (2004) · Nature Neuroscience · doi:10.1038/nn1271 · Cited by 122 · see citing works
GPCR-interacting proteins (GIPs): nature and functions
Bockaert, J., Roussignol, G., Bécamel, C., Gavarini, S., Joubert, L., Dumuis, A., Fagni, L., & Marin, P. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320851 · Cited by 105 · see citing works
Coordination of Synaptic Adhesion with Dendritic Spine Remodeling by AF-6 and Kalirin-7
Xie, Z., Photowala, H., Cahill, M. E., Srivastava, D. P., Woolfrey, K. M., Shum, C. Y., Huganir, R. L., & Penzes, P. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1170-08.2008 · Cited by 96 · see citing works
Self-citationRAMPs: the past, present and future
Parameswaran, N., & Spielman, W. S. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.09.006 · Cited by 94 · see citing works
Transmission disequilibrium studies of the serotonin 5‐HT2A receptor gene (HTR2A) in autism
Veenstra-VanderWeele, J. M., Kim, S., Lord, C., Yeung-Courchesne, R., Akshoomoff, N., LEVENTHAL, B. L., Courchesne, E., & Cook, E. H. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10192 · Cited by 92 · see citing works
5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation.
Roth, B. L., Pälvimäki, E.-P., Berry, S., Khan, N., Sachs, N. A., Uluer, A., & Choudhary, M. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12228-3 · Cited by 89 · see citing works
Self-citationXia, Z., Hufeisen, S. J., Gray, J. A., & Roth, B. L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00589-x · Cited by 87 · see citing works
Self-citationGABAB Receptor Association with the PDZ Scaffold Mupp1 Alters Receptor Stability and Function
Balasubramanian, S., Fam, S. R., & Hall, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607695200 · Cited by 82 · see citing works
BERG, K., Harvey, J., Spampinato, U., & Clarke, W. P. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00914-x · Cited by 81 · see citing works
Wang, H.-D., & Deutch, A. Y. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301521 · Cited by 80 · see citing works
The PDZ Protein Mupp1 Promotes Gi Coupling and Signaling of the Mt1 Melatonin Receptor
Guillaume, J., Daulat, A. M., Maurice, P., Levoye, A., Migaud, M., Brydon, L., Malpaux, B., Borg‐Capra, C., & Jockers, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802069200 · Cited by 77 · see citing works
Restivo, L., Roman, F. S., Dumuis, A., Bockaert, J., Marchetti, E., & Ammassari‐Teule, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301644 · Cited by 62 · see citing works
Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases
Allen, J., Yadav, P. N., & Roth, B. L. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.048 · Cited by 59 · see citing works
Self-citationNiitsu, Y., Hatnada, S., Hamaguchi, K., Mikuni, M., & Okado, N. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11805-7 · Cited by 41 · see citing works
Peddie, C. J., Davies, H. A., Colyer, F. M., Stewart, M. G., & Rodríguez, J. J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.003 · Cited by 39 · see citing works
The neuronal RhoA GEF, Tech, interacts with the synaptic multi‐PDZ‐domain‐containing protein, MUPP1
Estévez, M. A., Henderson, J. A., Ahn, D., Zhu, X., Poschmann, G., Lübbert, H., Marx, R., & Baraban, J. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05472.x · Cited by 38 · see citing works
Chapter 11 Modification of dendritic development
Feria‐Velasco, A., del Angel, A. R., & González‐Burgos, I. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)36013-8 · Cited by 30 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207 · see citing works
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · see citing works
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723 · see citing works
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739 · see citing works
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Shao, L.-X., Liao, C., Gregg, I., Davoudian, P. A., Savalia, N. K., Delagarza, K., & Kwan, A. C. (2021) · Neuron · doi:10.1016/j.neuron.2021.06.008 · Cited by 626 · see citing works
Dendritic Spines: The Locus of Structural and Functional Plasticity
Sala, C., & Segal, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00012.2013 · Cited by 465 · see citing works
Kraus, C., Castrén, E., Kasper, S., & Lanzenberger, R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.007 · Cited by 457 · see citing works
Lesch, K.-P., & Waider, J. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.013 · Cited by 435 · see citing works
The role of serotonin 5-HT2A receptors in memory and cognition
Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 386 · see citing works
Regulation of GPCR activity, trafficking and localization by GPCR‐interacting proteins
Magalhães, A. C., Dunn, H. A., & Ferguson, S. S. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01552.x · Cited by 352 · see citing works
The neural basis of psychedelic action
Kwan, A. C., Olson, D. E., Preller, K. H., & Roth, B. L. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01177-4 · Cited by 312 · see citing works
Self-citationHalberstadt, A. L., Chatha, M., Klein, A. K., Wallach, J., & Brandt, S. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107933 · Cited by 278 · see citing works
Barnes, N. M., Ahern, G. P., Bécamel, C., Bockaert, J., Camilleri, M., Chaumont‐Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C. F., Gershon, M. D., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 264 · see citing works
Self-citationMason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., Hutten, N. R. P. W., Jansen, J. F. A., Stiers, P., Feilding, A., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0718-8 · Cited by 258 · see citing works
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works
Classic hallucinogens in the treatment of addictions
Bogenschutz, M. P., & Johnson, M. W. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.002 · Cited by 226 · see citing works
de la Fuente Revenga, M., Zhu, B., Guevara, C. A., Naler, L. B., Saunders, J. M., Zhou, Z., Toneatti, R., Sierra, S., Wolstenholme, J. T., Beardsley, P. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109836 · Cited by 224 · see citing works
The Relationship between PSD-95 Clustering and Spine Stability <i>In Vivo</i>
Cane, M., Maco, B., Knott, G., & Holtmaat, A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3353-13.2014 · Cited by 216 · see citing works
Raval, N. R., Johansen, A., Donovan, L. L., Ros, N. F., Ozenne, B., Hansen, H. D., & Knudsen, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020835 · Cited by 200 · see citing works
The promises and perils of psychedelic pharmacology for psychiatry
McClure‐Begley, T. D., & Roth, B. L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00421-7 · Cited by 198 · see citing works
Self-citationRomero, G. G., von Zastrow, M., & Friedman, P. A. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00003-8 · Cited by 172 · see citing works
Brouwer, A., & Carhart-Harris, R. L. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120959637 · Cited by 159 · see citing works
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works
Serotonin Mediates Cross-Modal Reorganization of Cortical Circuits
Jitsuki, S., Takemoto, K., Kawasaki, T., Tada, H., Takahashi, A., Bécamel, C., Sano, A., Yuzaki, M., Zukin, R. S., Ziff, E. B., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.016 · Cited by 145 · see citing works
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
Dakic, V., Minardi Nascimento, J., Costa Sartore, R., Maciel, R. D. M., de Araujo, D. B., Ribeiro, S., Martins-de-Souza, D., & Rehen, S. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-12779-5 · Cited by 134 · see citing works
Insights into Rapid Modulation of Neuroplasticity by Brain Estrogens
Srivastava, D. P., Woolfrey, K. M., & Penzes, P. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005272 · Cited by 138 · see citing works
Self-citationSerotonergic signaling: multiple effectors and pleiotropic effects
Masson, J., Emerit, M. B., Hamon, M., & Darmon, M. C. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.50 · Cited by 132 · see citing works
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
Olson, D. E. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00812 · Cited by 135 · see citing works
Bogenschutz, M. P., & Pommy, J. M. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1376 · Cited by 125 · see citing works
Cortical reorganization after spinal cord injury: Always for good?
Moxon, K. A., Oliviero, A., Aguilar, J., & Foffani, G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.056 · Cited by 123 · see citing works
Maras, P. M., Molet, J., Chen, Y., Rice, C., Ji, S. G., Solodkin, A., & Baram, T. Z. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.12 · Cited by 118 · see citing works
Meltzer, H. Y., Rajagopal, L., Huang, M., Oyamada, Y., Kwon, S., & Horiguchi, M. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000928 · Cited by 114 · see citing works
PDZ Protein Regulation of G Protein–Coupled Receptor Trafficking and Signaling Pathways
Dunn, H. A., & Ferguson, S. S. G. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098509 · Cited by 108 · see citing works
Canalization and plasticity in psychopathology
Carhart-Harris, R. L., Chandaria, S., Erritzøe, D., Gazzaley, A. H., Girn, M., Kettner, H., Mediano, P. A. M., Nutt, D. J., Rosas, F. E., Roseman, L., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109398 · Cited by 103 · see citing works
Estrogen Receptor β Activity Modulates Synaptic Signaling and Structure
Srivastava, D. P., Woolfrey, K. M., Liu, F., Brandon, N. J., & Penzes, P. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3264-10.2010 · Cited by 102 · see citing works
Self-citationPsilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors
Shao, L.-X., Liao, C., Davoudian, P. A., Savalia, N. K., Jiang, Q., Wojtasiewicz, C., Tan, D., Nothnagel, J. D., Liu, R., Woodburn, S. C., et al. (2025) · Nature · doi:10.1038/s41586-025-08813-6 · Cited by 110 · see citing works
Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism
Bogenschutz, M. P., & Forcehimes, A. A. (2016) · Journal of Humanistic Psychology · doi:10.1177/0022167816673493 · Cited by 98 · see citing works
Regulation of the Actin Cytoskeleton in Dendritic Spines
Penzes, P., & Rafalovich, I. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_4 · Cited by 94 · see citing works
Self-citationBeyond the 5-HT2AReceptor: Classic and Nonclassic Targets in Psychedelic Drug Action
Cameron, L. P., Benetatos, J., Lewis, V., Bonniwell, E. M., Jaster, A. M., Moliner, R., Ċastrén, E., McCorvy, J. D., Palner, M., & Aguilar‐Valles, A. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1384-23.2023 · Cited by 93 · see citing works
Modulatory effects of cannabinoids on brain neurotransmission
Cohen, K., Weizman, A., & Weinstein, A. M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14407 · Cited by 92 · see citing works
Bender, D., & Hellerstein, D. J. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06049-6 · Cited by 88 · see citing works
Psychedelics and Neural Plasticity: Therapeutic Implications
Grieco, S. F., Castrén, E., Knudsen, G. M., Kwan, A. C., Olson, D. E., Zuo, Y., Holmes, T. C., & Xu, X. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1121-22.2022 · Cited by 82 · see citing works
“…psychedelics to researchers, has been shown to increase dendritic growth (Persico et al., 2006; Ohtani et al., 2014; Ly, Greb et al., 2018; Ly et al., 2021), synaptic puncta, spine density (Yoshida et al., 2011; Ly et al., 2018), and spine size (Jones et al., 2009) in cultured cortical neurons.”
Srivastava, D. P., Woolfrey, K. M., Jones, K. A., Anderson, C. T., Smith, K. R., Russell, T. A., Lee, H., Yasvoina, M. V., Wokosin, D. L., Özdi̇nler, P. H., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001350 · Cited by 85 · see citing works
Self-citationBlizinsky, K. D., Diaz-Castro, B., Forrest, M. P., Schürmann, B., Bach, A. P., Martin-de-Saavedra, M. D., Wang, L., Csernansky, J. G., Duan, J., & Penzes, P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607014113 · Cited by 76 · see citing works
Self-citationKozłowska, U., Nichols, C. D., Wiatr, K., & Figiel, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15509 · Cited by 80 · see citing works
5-HT2A receptors: Pharmacology and functional selectivity
Cummins, B. R., Billac, G. B., Nichols, D. E., & Nichols, C. D. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100059 · Cited by 79 · see citing works
Duan, W., Cao, D., Wang, S., & Cheng, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00375 · Cited by 79 · see citing works
Gong, Y., & Lippa, C. F. (2010) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317510382893 · Cited by 76 · see citing works
Control of dendritic spine morphological and functional plasticity by small GTPases.
Woolfrey, K. M., & Srivastava, D. P. (2016) · Neural Plasticity · doi:10.1155/2016/3025948 · Cited by 76 · see citing works
Self-citationSerotonylation and Transamidation of Other Monoamines
Muma, N. A., & Mi, Z. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500329r · Cited by 75 · see citing works
Fantegrossi, W. E., Wilson, C. D., & Berquist, M. D. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1428343 · Cited by 73 · see citing works
Therapeutic mechanisms of psychedelics and entactogens
Heifets, B. D., & Olson, D. E. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01666-5 · Cited by 67 · see citing works
Sustained Activation of Postsynaptic 5-HT2A Receptors Gates Plasticity at Prefrontal Cortex Synapses
Berthoux, C., Barre, A., Bockaert, J., Marin, P., & Bécamel, C. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy064 · Cited by 68 · see citing works
Analysis of Dendritic Spine Morphology in Cultured CNS Neurons
Srivastava, D. P., Woolfrey, K. M., & Penzes, P. (2011) · Journal of Visualized Experiments · doi:10.3791/2794 · Cited by 67 · see citing works
Self-citationPichon, X., Wattiez, A., Bécamel, C., Ehrlich, I., Bockaert, J., Eschalier, A., Marin, P., & Courteix, C. (2010) · Molecular Therapy · doi:10.1038/mt.2010.101 · Cited by 66 · see citing works
The polypharmacology of psychedelics reveals multiple targets for potential therapeutics
Jain, M. K., Gumpper, R. H., Slocum, S. T., Schmitz, G. P., Madsen, J. S., Tummino, T. A., Suomivuori, C., Huang, X.-P., Shub, L., DiBerto, J. F., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.06.012 · Cited by 66 · see citing works
Self-citationRoth, B. L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.012 · Cited by 66 · see citing works
Self-citationPsychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 65 · see citing works
Psychedelics as a Treatment for Alzheimer’s Disease Dementia
Jones, S. V., & O’Kelly, A. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.00034 · Cited by 62 · see citing works
Molecular insights into psychedelic drug action
Slocum, S. T., DiBerto, J. F., & Roth, B. L. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15540 · Cited by 56 · see citing works
Self-citationDukhinova, M., Kuznetsova, I. S., Kopeikina, E., Veniaminova, E. A., Yung, A. W. Y., Veremeyko, T., Levchuk, K., Barteneva, N. S., Wing-Ho, K. K., Yung, W., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.009 · Cited by 60 · see citing works
Alba‐Delgado, C., Mountadem, S., Mermet-Joret, N., Monconduit, L., Dallel, R., Artola, A., & Antri, M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1294-18.2018 · Cited by 60 · see citing works
Aznar, S., & Klein, A. B. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8472-0 · Cited by 58 · see citing works
Phosphatidic acid in neuronal development: A node for membrane and cytoskeleton rearrangements
Ammar, M.-R., Kassas, N., Bader, M. F., & Vitale, N. (2014) · Biochimie · doi:10.1016/j.biochi.2014.07.026 · Cited by 58 · see citing works
5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice
Jefferson, S. J., Gregg, I., Dibbs, M., Liao, C., Wu, H., Davoudian, P. A., Woodburn, S. C., Wehrle, P. H., Sprouse, J. S., Sherwood, A. M., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01572-w · Cited by 56 · see citing works
Franklin, J. M., & Carrasco, G. A. (2012) · Synapse · doi:10.1002/syn.21626 · Cited by 56 · see citing works
Psychedelics as Transformative Therapeutics
Roth, B. L., & Gumpper, R. H. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230172 · Cited by 54 · see citing works
Self-citationSerotonin modulates excitatory synapse maturation in the developing prefrontal cortex
Ogelman, R., Wulschner, L. E. G., Hoelscher, V. M., Hwang, I.-W., Chang, V. N., & Oh, W. C. (2024) · Nature Communications · doi:10.1038/s41467-024-45734-w · Cited by 54 · see citing works
Horsley, R. R., Páleníček, T., Kolin, J., & Valeš, K. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000394 · Cited by 52 · see citing works
Effinger, D. P., Quadir, S. G., Ramage, M. C., Cone, M. G., & Herman, M. A. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02414-5 · Cited by 50 · see citing works
Lysergic acid diethylamide: a drug of ‘use’?
Das, S., Barnwal, P., Ramasamy, A., Sen, S., & Mondal, S. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316640440 · Cited by 50 · see citing works
Epac2-mediated dendritic spine remodeling: Implications for disease
Penzes, P., Woolfrey, K. M., & Srivastava, D. P. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.11.008 · Cited by 47 · see citing works
Self-citationLeung, C., & Wong, Y. (2017) · Molecules · doi:10.3390/molecules22071239 · Cited by 48 · see citing works
KALRN: A central regulator of synaptic function and synaptopathies
Parnell, E., Shapiro, L. P., Voorn, R. A., Forrest, M. P., Jalloul, H. A., Loizzo, D. D., & Penzes, P. (2020) · Gene · doi:10.1016/j.gene.2020.145306 · Cited by 47 · see citing works
Self-citationMartin, H., Bullich, S., Guiard, B. P., & Fioramonti, X. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12928 · Cited by 48 · see citing works
Rapid Estradiol Modulation of Neuronal Connectivity and Its Implications for Disease
Srivastava, D. P., & Penzes, P. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00077 · Cited by 44 · see citing works
Self-citationKalrnplays key roles within and outside of the nervous system
Mandela, P., Yankova, M. P., Conti, L. H., Ma, X., Grady, J., Eipper, B. A., & Mains, R. E. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-136 · Cited by 43 · see citing works
Mi, Z., Si, T., Kapadia, K., Li, Q., & Muma, N. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.034 · Cited by 43 · see citing works
The structural diversity of psychedelic drug actions revealed
Gumpper, R. H., Jain, M. K., Kim, K., Sun, R., Sun, N., Xu, Z., DiBerto, J. F., Krumm, B. E., Kapolka, N. J., Kanıskan, H. Ü., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57956-7 · Cited by 44 · see citing works
Self-citationAbnormal kalirin signaling in neuropsychiatric disorders
Remmers, C. L., Sweet, R. A., & Penzes, P. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.006 · Cited by 43 · see citing works
Self-citationShahar, O., Botvinnik, A., Shwartz, A., Lerer, E., Golding, P., Buko, A., Hamid, E., Kahn, D., Guralnick, M., Blakolmer, K., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02477-w · Cited by 40 · see citing works
Morgan, C. J. A., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.10.009 · Cited by 42 · see citing works
Effects of antipsychotic drugs on neurites relevant to schizophrenia treatment
Huang, X., & Song, X. (2018) · Medicinal Research Reviews · doi:10.1002/med.21512 · Cited by 42 · see citing works
Russell, T. A., Blizinsky, K. D., Cobia, D. J., Cahill, M. E., Xie, Z., Sweet, R. A., Duan, J., Gejman, P. V., Wang, L., Csernansky, J. G., et al. (2014) · Nature Communications · doi:10.1038/ncomms5858 · Cited by 39 · see citing works
Self-citationCatalysts for change: the cellular neurobiology of psychedelics
Banks, M. I., Zahid, Z., Jones, N., Sultan, Z. W., & Wenthur, C. J. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-05-0340 · Cited by 37 · see citing works
Two-Step Wiring Plasticity – A mechanism for estrogen-induced rewiring of cortical circuits
Srivastava, D. P. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.01.006 · Cited by 37 · see citing works
Self-citationKalirin Signaling: Implications for Synaptic Pathology
Penzes, P., & Remmers, C. L. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8223-z · Cited by 36 · see citing works
Self-citationXu, C., Ma, X.-M., Chen, H.-B., Zhou, M.-H., Qiao, H., & An, S.-C. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.020 · Cited by 34 · see citing works
Bai, Y., Xiang, X., Liang, C., & Shi, L. (2015) · BioMed Research International · doi:10.1155/2015/632450 · Cited by 40 · see citing works
Ma, X., Miller, M. B., Vishwanatha, K. S., Gross, M. J., Wang, Y., Abbott, T. B., Lam, T. T., Mains, R. E., & Eipper, B. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-04-0215 · Cited by 35 · see citing works
Physical activity promotes brain development through serotonin during early childhood
Jing, J.-Q., Jia, S.-J., & Yang, C.-J. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.015 · Cited by 34 · see citing works
Hippocampal phenotypes in kalirin-deficient mice
Xie, Z., Cahill, M. E., Radulovic, J., Wang, J., Campbell, S. L., Miller, C. A., Sweatt, J. D., & Penzes, P. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.08.005 · Cited by 34 · see citing works
Self-citationWalther, C., Caetano, F. A., Dunn, H. A., & Ferguson, S. S. G. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2014.12.019 · Cited by 33 · see citing works
Yu, X., Yao, H., Zhang, X., Liu, L., Liu, S., & Dong, Y. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04233-2 · Cited by 33 · see citing works
The role of serotonin neurotransmission in rapid antidepressant actions
Pehrson, A. L., Roberts, D., Khawaja, A., & McNair, R. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06098-5 · Cited by 33 · see citing works
The Effects of Psychedelics on Neuronal Physiology
Hatzipantelis, C. J., & Olson, D. E. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042022-020923 · Cited by 32 · see citing works
Wulff, A. B., Nichols, C. D., & Thompson, S. M. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109504 · Cited by 34 · see citing works
Subtype specific roles of serotonin receptors in the spine formation of cortical neurons in vitro
Yoshida, H., Kanamaru, C., Ohtani, A., Li, F., Senzaki, K., & Shiga, T. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.07.1824 · Cited by 33 · see citing works
Serotonergic Psychedelics in Neural Plasticity
Łukasiewicz, K., Baker, J. J., Zuo, Y., & Lu, J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.748359 · Cited by 31 · see citing works
Stress-Sensitive Protein Rac1 and Its Involvement in Neurodevelopmental Disorders
Wang, X., Liu, D., Wei, F., Li, Y., Wang, X., Li, L., Wang, G., Zhang, S., & Zhang, L. (2020) · Neural Plasticity · doi:10.1155/2020/8894372 · Cited by 30 · see citing works
- Authors
- Jones, K. A., Srivastava, D. P., Allen, J. A., Strachan, R. T., Roth, B. L., & Penzes, P.
- Affiliations
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- Case Western Reserve University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-11-17
- Volume
- 106
- Issue
- 46
- Pages
- 19575-19580
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2780750
- OpenAlex
- W2143648030
- Cited by
- 226
- References
- 45
- Citations by year
- 2026: 16 · 2025: 13 · 2024: 14 · 2023: 27 · 2022: 14 · 2021: 21 · 2020: 15 · 2019: 6 · 2018: 11 · 2017: 8 · 2016: 8 · 2015: 11 · 2014: 14 · 2013: 14 · 2012: 14
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- UNC Libraries
- Funders
- Alzheimer's Association
- American Heart Association
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health (n01mh32004-8-0-0, U19MH82441)
- National Institute of Mental Health (U19MH082441, U19-MH82441, R01MH061887, R01MH61887, F31MH085362, N01 MH032004, R01MH071316)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD040127)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- 5-HT2A receptor, Kalirin-7, dendritic spine morphogenesis, cortical pyramidal neurons, p21-activated kinase, postsynaptic density, MUPP1, PSD-95, digital object identifiers, serotonin signaling, synaptic plasticity
- MeSH terms
- Animals, Carrier Proteins, Dendrites, Morphogenesis, Neuronal Plasticity, Spine, Synapses, Rats, Sprague-Dawley, Pyramidal Cells, Guanine Nucleotide Exchange Factors, Receptor, Serotonin, 5-HT2A, Intracellular Signaling Peptides and Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review